Neurol. praxi. 2015;16(1):10-13

Pathophysiology of spasticity

prof. MUDr. Petr Kaňovský, CSc.
Komplexní centrum spasticity, Neurologická klinika LF UP a FN Olomouc

Spasticity is defined as impaired muscle tone (hypertonia) caused by an increase in tonic stretch reflexes that is dependent on the speed of passive muscle stretching, and this increase in tonic stretch reflexes is likely to directly result from abnormal processing and modulation of proprioceptive impulses conducted by class Ia and Ib proprioceptive fibres, in the eloquent cortex in the brain. In the clinical setting, spasticity is a part of upper motor neuron syndrome, being one of the so-called positive signs. It is accompanied by other phenomena that are a manifestation of abnormal excitatory as well as inhibitory supraspinal descending drive: flexor spasms, clasp-knife phenomenon, efferent drive, and associated reactions. Recently, major importance in the genesis of spasticity and its therapeutic management has been attributed to the plasticity of the cerebral cortex.

Keywords: spasticity, pathophysiology, plasticity of cerebral cortex

Published: January 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kaňovský P. Pathophysiology of spasticity. Neurol. praxi. 2015;16(1):10-13.
Download citation

References

  1. Brown P. Pathophysiology of spasticity. J. Neurol Neurosurg Psychiatr 1994; 57: 773-777. Go to original source... Go to PubMed...
  2. Burchiel KJ, Hsu, FP. Pain and spasticity after spinal cord injury: mechanisms and treatment. Spine 2001; 26(Suppl. 1): S146-S160. Go to original source... Go to PubMed...
  3. Cuadrado ML, Arias JA, Palomar MA, Linares R. The pyramidal tract: new pathways. Rev Neurol 2001; 32: 1151-1158. Go to original source...
  4. Decq P. Pathophysiology of spasticity. Neurochirurgie 2003; 49: 163-184. Go to PubMed...
  5. Denny-Brown D. The stretch reflex as a spinal proces. J Physiol 1927; 63: 144-150. Go to original source... Go to PubMed...
  6. Denny-Brown D. The nature of dystonia. Bull NY Acad Med 1965; 41: 858-869.
  7. Dietz V. Spinal cord lesion: effects of and perspectives for treatment. Neural Plast 2001; 8: 83-90. Go to original source... Go to PubMed...
  8. Friden J, Lieber RL. Spastic muscle cells are shorter and stiffer than normal cells. Muscle Nerve 2003; 27: 157-164. Go to original source... Go to PubMed...
  9. Gracies JM. Pathophysiology of spastic paresis I: Paresis and soft tissue changes. Muscle Nerve 2005; 31: 535-551 (a). Go to original source... Go to PubMed...
  10. Gracies JM. Pathophysiology of spastic paresis II: Emergence of muscle overactivity. Muscle Nerve 2005; 31: 552-571 (b). Go to original source... Go to PubMed...
  11. Havsteen I, Madsen KH, Christensen H, Christensen A, Siebner HR. Diagnostic approach to functional recovery: functional magnetic resonance imaging after stroke. Front Neurol Neurosci 2013; 32: 9-25. Go to original source... Go to PubMed...
  12. Jankowska E, Hammar I. Spinal interneurones; how can studies in animals contribute to the understanding of spinal interneuronal systems in man? Brain Res Rev 2002; 40: 19-28. Go to original source... Go to PubMed...
  13. Kaňovský P, Bareš M, Dufek J. Spasticita: patofyziologie, diagnostika a léčba. Maxdorf, Praha 2004.
  14. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP eds. Spasticity: disordered motor control. Chicago, Year Book Medical Pubs, 1980: 487-489.
  15. Lieber RL, Frieden J. Spasticity causes a fundamental rearrangement of muscle-joint interaction. Muscle Nerve 2002; 25: 265-270. Go to original source... Go to PubMed...
  16. Mirbagheri MM, Barbeau H, Ladouceur M, Kearney RE. Instrinsic and reflex siffness in normal and spastic spinal cord injured subjects. Exp Brain Res 2001; 141: 446-459. Go to original source... Go to PubMed...
  17. Okuma Y, Mizuno Y, Lee RG. Reciprocal Ia inhibition in patients with asymmetric spinal spasticity. Clin Neurophysiol 2002; 113: 292-297. Go to original source... Go to PubMed...
  18. Rosales R, Dressler D. On muscle spindles, dystonia and botulinum toxin. Eur J Neurol 2010; 17(Suppl. 1): 71-80. Go to original source... Go to PubMed...
  19. Rosales R, Kaňovský P, Fernandez H. What's the "catch" in the upper-limb post-stroke spasticity: expanding the role of botulinum toxin interaction. Park Relat Disord 2011; 17(Suppl. 1): S3-S10 Go to original source... Go to PubMed...
  20. Sheean G. The pathophysiology of spasticity. Eur J Neurol 2002; 9(Suppl. 1): 3-9. Go to original source... Go to PubMed...
  21. Sheean G, McGuire JR. Spastic hypertonia and movement disorders: pathophysikology, clinical presentation and quantification. PM R 2009; 1: 827-833. Go to original source... Go to PubMed...
  22. Šenkárová Z, Hluštík P, Otruba P, Herzig R, Kaňovský P. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study. J Neuroimaging 2010; 20: 9-15. Go to original source... Go to PubMed...
  23. Štětkářová I, Kofler M. Differential effect of baclofen on cortical and spinal inhibitory circuits. Clin Neurophysiol 2013; 124: 339-345. Go to original source... Go to PubMed...
  24. Tomášová Z, Hluštík P, Král M, Otruba P, Herzig R, Krobot A, Kaňovský P. Cortical activation chamges in patients suffering from post-stroke arm spasticity and treated with botulinum toxin A. J Neuroimaging 2013; 23: 337-344. Go to original source... Go to PubMed...
  25. Veverka T, Hluštík P, Tomášová Z, Hok P, Otruba P, Král M, Tüdös Z, Zapletalová J, Herzig R, Krobot A, Kaňovský P. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke. J Neurol Sci 2012; 319: 89-95. Go to original source... Go to PubMed...
  26. Veverka T, Hluštík P, Hok P, Tomášová Z, Otruba P, Král M, Tüdös Z, Krobot A, Herzig R, Kaňovský P. Differences in the modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A. Czech Slovak Neur Neurochir 2013; 76: 175-182.
  27. Veverka T, Hluštík P, Hok P, Otruba P, Krobot A, Kaňovský P. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement. J Neurol Sci 2014, 346: 276-283. Go to original source... Go to PubMed...
  28. Ward AB. A literature review of the pathophysiology and onset of post-stroke spasticity. Eur J Neurol 2012; 19: 21-27. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.